Till Milde

发表

DNA methylation-based classification of central nervous system tumours

Till Acker, Pieter Wesseling, Martin Sill, 2018, Nature.

Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions

Stefan M. Pfister, Damian Stichel, Andreas von Deimling, 2019, Acta Neuropathologica.

The whole-genome landscape of medulloblastoma subtypes

Roland Eils, Steven J. M. Jones, Sebastian M. Waszak, 2017, Nature.

Dissecting the genomic complexity underlying medulloblastoma

Matthew J. Betts, Robert B. Russell, Roland Eils, 2012, Nature.

Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets

Stefan M. Pfister, Ivo Buchhalter, Benedikt Wiestler, 2016, Acta Neuropathologica.

HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment

Stefan M. Pfister, Andrey Korshunov, Till Milde, 2012, Journal of Neuro-Oncology.

Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.

Roland Eils, Rainer König, Gary D Bader, 2014, Cancer cell.

Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

Roland Eils, Thomas Zichner, Hans Lehrach, 2013, Nature Genetics.

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort

Roland Eils, Thomas Zichner, Arie Perry, 2018 .

Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive–like behaviors in mice

Shahin Rafii, Till Milde, Kevin G Bath, 2010, Nature Medicine.

Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience

Martin Sill, Volker Hovestadt, Stefan M. Pfister, 2018, Acta Neuropathologica.

Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.

Gary D Bader, Martin Sill, Axel Benner, 2011, Cancer cell.

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

Roland Eils, Pieter Wesseling, Martin Sill, 2016, Cell.

Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes.

Roland Eils, Volker Hovestadt, Jan Koster, 2016, Cancer cell.

INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies

Michael Platten, Annette Kopp-Schneider, Stefan M. Pfister, 2020, BMC Cancer.

Therapeutic Targeting of Ependymoma as Informed by Oncogenic Enhancer Profiling

Anne Song, Stefan M. Pfister, Paul A. Northcott, 2017, Nature.